Ticker League

West Pharmaceutical Services (WST) Free Cash Flow Bridge

Pinpoint what moved West Pharmaceutical Services's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+49.23%

OCF YoY

+7.63%

Capex YoY

-28.07%

FCF Conversion Δ

+17.9 pp

Free cash flow bridge for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $151.10M

FCF bridge breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$306.90M
  • Operating Cash Flow$50.70M
  • Capital Expenditure$100.40M
  • Free Cash Flow$458.00M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology